AHA 2017 Scientific Sessions
Direct Oral Anticoagulant Use Increasing in Dialysis Patients With AFib
End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.
Your search for esrd returned 20 results
SABCS 2021
Elacestrant Improved PFS in Metastatic Breast Cancer Progressing on CDK4/6 Therapy
Elacestrant showed a statistically significant and clinically meaningful progression-free survival improvement compared with standard of care.
SABCS 2022
Camizestrant Improves PFS vs Fulvestrant in ER+/HER2- Advanced Breast Cancer
Camizestrant improved progression-free survival vs fulvestrant in postmenopausal patients with ER+, HER2- advanced breast cancer.
American College of Cardiology 2011
Lipid Management in Special Populations
Statins are the most widely prescribed agents in the world. While muscle-related adverse effects associated with statins are well known, accurately quantifying their incidence to guide clinicians with respect to lipid management can be difficult, said Richard H. Karas, MD, PhD, Tufts Medical Center, Boston, at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.
SABCS 2021
Monitoring ESR1 Mutations May Optimize Treatment in Metastatic Breast Cancer
Monitoring bESR1mut enabled optimization of the endocrine therapy used with a CDK4/6 inhibitor.
SABCS 2022
Duration of Prior CDK4/6 Inhibitor Treatment Tied to PFS With Elacestrant
The duration of prior treatment with a CDK4/6 inhibitor appears to impact progression-free survival with elacestrant in ER+/HER2- metastatic breast cancer.
AAAAI 2017
Is IL-5 Inhibition Effective in NSAIDs-Exacerbated Respiratory Disease?
Based on the pathophysiological and clinical characteristics of N-ERD, anti-IL 5 therapy may be effective in this patient subgroup.
PainWeek 2013
The Search for Clinical Inflammatory Markers for Centralized, Intractable Pain
Multiple inflammatory markers should simultaneously be tested to best detect unresolved inflammation in pain patients according to results presented at PAINWeek 2013 from a study conducted by pain specialist Forest Tennant, MD, DrPH.
ACR/ARHP Annual Meeting 2013
CZP + MTX Demonstrate Favorable Long-Term Efficacy in Active RA
At the 2013 ACR/ARHP Annual Meeting, study authors presented that patients with active rheumatoid arthritis (RA) despite methotrexate (MTX), certolizumab pegol (CZP) + MTX maintained reduction in signs and symptoms through 5 years.
CHEST 2020
Increased GERD Risk in End-Stage Lung Disease Without Esophageal Disease
End-stage lung disease may significantly increase the risk for gastroesophageal reflux disease (GERD) in patients undergoing lung transplant without primary esophageal disease.
